Tradestie Institutional Equity Comparison Engine
VVOS vs ABNG โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABNG Overall Edge
ABNG Captures Institutional Edge (2โ1 Pillars ยท 3โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ABNG (ABNG) driven by superior Momentum & Technical, Options & Structure while VVOS counters with relative strength in Growth & Margin. Fundamentally, VVOS trades at N/M Forward P/E with -107.9% operating margin (+34.9% YoY revenue) versus ABNG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, VVOS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ABNG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
VVOS N/M vs ABNG N/M Fwd P/E
Growth & Margin Winner
VVOS
Op Margin -107.9% vs N/A ยท YoY +34.9% vs N/A
Momentum & Technical Winner
ABNG
1Y -97.7% vs +45.3% ยท 52W Pos 0% vs 100%
Options & Structure Winner
ABNG
BREAKDOWN (N/A IV) vs UNCLASSIFIED (N/A IV)
VVOS
NASDAQ
Vivos Therapeutics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$0.05
-5.1% 1D
Market Cap
$1.9M
1M Return
-59.25%
1Y Return
-97.71%
Forward P/E
N/M
Unified AI Score
36.4 / 100
SELL
Tech 25.0
Fund 35.0
Flow 50.0
Mom 30.0
ABNG
US Equity
ABNG
Institutional Equity
$20.21
+8.39% 1D
Market Cap
N/A
1M Return
+8.73%
1Y Return
+45.31%
Forward P/E
N/M
Unified AI Score
53.0 / 100
HOLD
Tech 55.0
Fund 56.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
VVOS -97.71%
ABNG +45.31%
Spread: +135.45 pp (ABNG Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
VVOS TTM Op. Margin: -107.9%
ABNG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VVOS vs ABNG. Trailing 12-month operating profitability (VVOS -107.9% vs ABNG N/A) and valuation multiples (VVOS N/M vs ABNG N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | VVOS | ABNG | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.9M | N/A | Larger Scale | VVOS |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +34.9% | N/A | Higher Growth | VVOS |
| Operating Margin (TTM) Profitability | -107.9% | N/A | Higher Margin | VVOS |
| Net Profit Margin Profitability | -121.8% | N/A | Higher Margin | VVOS |
| Return on Equity (ROE) Capital Efficiency | -8585.3% | N/A | Higher ROE | VVOS |
| 52-Week Range Position Momentum | 0% ($0โ$3) | 100% ($13โ$20) | Stronger Trend | ABNG |
| Beta / 30D Volatility Risk Regime | 1.70ฮฒ ยท 111% Vol | 2.34ฮฒ ยท 71% Vol | Lower Realized Risk | ABNG |
| Unified Institutional Score Composite Signal | 36.4 / 100 (SELL) | 53.0 / 100 (HOLD) | Higher Composite | ABNG |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full VVOS vs ABNG Buy Guide
VVOS
BREAKDOWN
113d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
ABNG
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither VVOS nor ABNG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.